Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature

scientific article

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.LUNGCAN.2004.08.016
P698PubMed publication ID15713522

P2093author name stringDavid Johnson
Frances A Shepherd
Lesley Seymour
Barbara Graham
James Rigas
Keyue Ding
Robert Livingston
Timothy Winton
Marlo Whitehead
Naveed Alam
P433issue3
P921main subjectCanadaQ16
chemotherapyQ974135
P304page(s)385-394
P577publication date2005-03-01
P1433published inLung CancerQ641464
P1476titleCompliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature
P478volume47

Reverse relations

cites work (P2860)
Q36752521A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer
Q37228519Adjuvant chemotherapy after complete resection of non-small cell lung cancer
Q35771994Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Q35200745Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
Q35200660Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).
Q34126484Adjuvant chemotherapy of non-small cell lung cancer
Q80420032Chemotherapy and surgery for operable NSCLC
Q43948093Chemotherapy compliance in patients with osteosarcoma
Q33924664Clinical symptoms and chemotherapy completion in elderly patients with newly diagnosed acute leukemia: a retrospective comparison study with a younger cohort
Q41208260Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance
Q85303113ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lung cancer
Q33594314Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients
Q63532892Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions
Q35044346Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer
Q36467456Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.
Q24194081Immunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intent
Q43197895Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer
Q37240128Non-small cell lung cancer in the elderly: defining treatment options
Q52928581Operative outcomes of thoracoscopic lobectomy for non-small-cell lung cancer.
Q35003631Pemetrexed for the treatment of non-small-cell lung cancer
Q33429178Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
Q37346454Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers
Q50109053Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
Q37089137Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience
Q48846109Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants
Q37347493Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial
Q37119462Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
Q99582717Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
Q33404434Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
Q39732809Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy.
Q34564943Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants?
Q43604929Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
Q30417605The Peter Brojde lung cancer centre: a model of integrative practice
Q38833767Therapeutic options following pneumonectomy in non-small cell lung cancer
Q30249083Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice.
Q28209997Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol
Q36977683UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction
Q35674874Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer
Q83298998[Interdisciplinary treatment of non-small cell lung cancer]

Search more.